principal components drug
Evidence from:
primary |
all sources
Related entities (4)
| Subject | Relation | Object | p-value | Evidence |
|---|---|---|---|---|
| African American | associated_with | principal components | — | 1 |
| European ancestry | associated_with | principal components | — | 1 |
| His | associated_with | principal components | — | 1 |
| SAGE | associated_with | principal components | — | 1 |
Mentioned in (3)
Papers in which this entity is mentioned.
- Genome-wide mutational signatures in low-coverage whole genome sequencing of cell-free DNA. (2022)
- Comprehensive analyses of tumor immunity: implications for cancer immunotherapy. (2016)
- Tackling the widespread and critical impact of batch effects in high-throughput data. (2010)
Merged raw entities (4)
All extracted name/type variants the normalize job merged into this entity. Use this to spot wrong merges, or aliases that should be split off.
| Raw name | Type | Papers | Mentions |
|---|---|---|---|
| pc | drug | 6 | 18 |
| principal components | drug | 4 | 4 |
| pc1 | drug | 3 | 4 |
| pc2 | drug | 2 | 3 |